leisure time -WSS

leisure time

author：leisure time 2025-08-25 06:01:08 - browse：1491

Cambridge: AbbVie — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Faced with fears of OxyContin misuse, sales reps touted its safety

WSS

GOP presidential candidates start declaring their loyalty

Listen: Your guide to Wegovy's blockbuster heart study

Listen: Your guide to Wegovy's blockbuster heart study

Novo acquires Inversago for up to $1 billion

Cancer cells are shown to suck energy source from immune cells

An innovative path out of biotech’s “valley of death”

knowledge

leisure time

Wikipedia

Peter Hotez and the public health issue of online harassment

Life sciences deals on track to hit lowest point since 2017

Hepatitis C has a cure — but many Americans still lack access to it

Readout LOUD podcast: Merger Mondays, Ozempic panic

Anesthesiologist group: stop taking Ozempic before surgery

Covid's long

Trump demands the U.S. pay no more for drugs than other countries … again

STAT Readout: Today's biotech news includes Sana and Amylyx

Affirmative action in medical school literally saved lives

Peter Marks talks Operation Warp Speed for Rare Diseases

entertainment

White House drug shortages task force keeps mum with Congress

European regulators consider appeal over Amylyx ALS drug

Readout LOUD podcast: Merger Mondays, Ozempic panic

European regulators consider appeal over Amylyx ALS drug

The history of OxyContin, told through Purdue Pharma documents

Pharma budget tightening trickles down to Doximity

Wikipedia

knowledge

knowledge

knowledge